News

Top news of the day from across the health care landscape.
Vaccine found to provide durable protection against the “death star” HIV strain, which is notably hard to fight.
Researchers aimed to determine the potential pathology of encephalitis as a complication of immunotherapy treatment.
Top news of the day from across the health care landscape.
Erdafitinib (Balversa, Janssen) is the first FGFR inhibitor to receive FDA approval for the treatment of patients with metastatic bladder cancer marked by FGFR gene mutations.
Top news of the day from across the health care landscape.
Administered through a drug-eluting implant, islatravir demonstrated protection against HIV for up to 12 months.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$